NeoGenomics (NEO) Reports In-Line Q3 Loss

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $25.66 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Evercore ISI Reiterates Underperform Rating on Lennar (LEN)